Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

International Study for Treatment of High Risk Childhood Relapsed ALL 2010 A Randomized Phase II Study Conducted by the Resistant Disease Committee of the International Berlin, Frankfurt, Münster (BFM) Study Group

NCT03590171 is registered in ClinicalTrials.gov with Charite University, Berlin, Germany as lead sponsor.

NCT NCT03590171
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03590171 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
International Study for Treatment of High Risk Childhood Relapsed ALL 2010 A Randomized Phase II Study Conducted by the Resistant Disease Committee of the International Berlin, Frankfurt, Münster (BFM) Study Group
Lead sponsor
Charite University, Berlin, Germany
Phase
Phase 2
Overall status
Recruiting
Start date
September 1, 2017
Completion date
December 31, 2027
Enrollment
250 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia (all)